DE3578620D1 - Arzneimittel zur aeusserlichen anwendung. - Google Patents

Arzneimittel zur aeusserlichen anwendung.

Info

Publication number
DE3578620D1
DE3578620D1 DE8585111034T DE3578620T DE3578620D1 DE 3578620 D1 DE3578620 D1 DE 3578620D1 DE 8585111034 T DE8585111034 T DE 8585111034T DE 3578620 T DE3578620 T DE 3578620T DE 3578620 D1 DE3578620 D1 DE 3578620D1
Authority
DE
Germany
Prior art keywords
external use
medicinal products
medicinal
products
external
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585111034T
Other languages
English (en)
Inventor
Yuji Makino
Hideo Matugi
Yoshiki Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of DE3578620D1 publication Critical patent/DE3578620D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585111034T 1984-09-03 1985-09-02 Arzneimittel zur aeusserlichen anwendung. Expired - Lifetime DE3578620D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59182724A JPS6160620A (ja) 1984-09-03 1984-09-03 ピログルタミン酸エステル類を含有する医薬品組成物

Publications (1)

Publication Number Publication Date
DE3578620D1 true DE3578620D1 (de) 1990-08-16

Family

ID=16123333

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585111034T Expired - Lifetime DE3578620D1 (de) 1984-09-03 1985-09-02 Arzneimittel zur aeusserlichen anwendung.

Country Status (5)

Country Link
US (1) US4789667A (de)
EP (1) EP0173990B1 (de)
JP (1) JPS6160620A (de)
DE (1) DE3578620D1 (de)
MY (1) MY100947A (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272953A (en) * 1984-10-08 1990-08-21 Yuji Makino Pharmaceutical composition for external use containing active-type vitamin d.sub.3
JPS61103840A (ja) * 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物
US4762851A (en) * 1985-11-29 1988-08-09 Merck & Co., Inc. Pyroglutamic acid esters used as dermal penetration enhancers for drugs
EP0276643A3 (de) * 1986-09-04 1988-08-24 Jan Coppe Haarwuchsmittel
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
DE3726797A1 (de) * 1987-08-12 1989-02-23 Bayer Ag Arzneimittel fuer den bereich der mundhoehle
US5059628A (en) * 1987-09-28 1991-10-22 Nitto Electric Industrial Co., Ltd. Medical composition for percutaneous administration
EP0327756B1 (de) * 1987-11-13 1994-01-26 Smithkline Beecham Farmaceutici S.p.A. Ein Calcitonin sowie ein Glycyrrhizinat als Absorptionsförderer enthaltende Arzneimittel
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB8811409D0 (en) * 1988-05-13 1988-06-15 Unilever Plc Cosmetic composition
US5026825A (en) * 1988-09-08 1991-06-25 Rhone-Poulenc Rorer Pharmaceuticals Inc. Intranasal calcitonin formulations
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
US4950664A (en) * 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
US5244880A (en) * 1988-11-02 1993-09-14 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Stable aqueous solutions of prymicin and pharmaceutical and cosmetic compositions containing these solutions
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
US5059603A (en) * 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
SE464167B (sv) * 1989-07-31 1991-03-18 Analytecon Sa Topisk farmaceutisk beredning av podophyllotoxin
JP3273430B2 (ja) * 1989-12-28 2002-04-08 日東電工株式会社 エストロゲン含有ゲル製剤
JP2820306B2 (ja) * 1990-02-27 1998-11-05 積水化学工業株式会社 経皮吸収製剤
DK0453603T3 (da) * 1990-04-26 1993-11-22 Com Pharm Arzneimittel Gmbh Piroxicamholdige farmaceutiske præparater til topisk anvendelse
US5780012A (en) * 1990-06-21 1998-07-14 Huland; Edith Method for reducing lung afflictions by inhalation of cytokine solutions
DE59007645D1 (de) * 1990-06-21 1994-12-08 Edith Dr Huland Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst.
US5332576A (en) * 1991-02-27 1994-07-26 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
AU2259692A (en) * 1991-07-03 1993-02-11 Sano Corporation Composition and method for transdermal delivery of diclofenac
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
JP3202777B2 (ja) * 1992-01-24 2001-08-27 リンテック株式会社 経皮吸収促進剤及びテープ製剤
JP2523428B2 (ja) * 1992-12-04 1996-08-07 エスエス製薬株式会社 消炎鎮痛ゲル製剤
WO1995004520A1 (en) * 1993-08-06 1995-02-16 Embro William J Method and composition for treating muco-epidermal and epidermal pain, inflammation and infection
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5906814A (en) * 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US6572874B1 (en) 1998-05-15 2003-06-03 Umd, Inc. Vaginal delivery of bisphosphonates
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6416779B1 (en) 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
GB9822150D0 (en) * 1998-10-09 1998-12-02 Dignes Roy Ultrasound driven devices for accelerated transfer of substances across porous boundaries
US6262117B1 (en) 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20040033260A1 (en) * 1999-10-19 2004-02-19 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
WO2001043698A1 (en) * 1999-12-15 2001-06-21 Carter Donald R Topical ointment
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US7910641B2 (en) 2001-10-12 2011-03-22 Monosol Rx, Llc PH modulated films for delivery of actives
US7425292B2 (en) 2001-10-12 2008-09-16 Monosol Rx, Llc Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
US7666337B2 (en) 2002-04-11 2010-02-23 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8017150B2 (en) 2002-04-11 2011-09-13 Monosol Rx, Llc Polyethylene oxide-based films and drug delivery systems made therefrom
US20040241100A1 (en) * 2003-03-17 2004-12-02 Fabre Kramer Pharmaceutical, Inc. Nasally administrable compositions of zolpidem and methods of use
CN100469391C (zh) * 2004-06-10 2009-03-18 安米 人溶菌酶在制备治疗痤疮的药物中的应用
WO2006078824A2 (en) * 2005-01-18 2006-07-27 Biova, L.L.C. Eggshell membrane separation method
US8418943B2 (en) 2005-01-18 2013-04-16 Biova, L.L.C. Egg shell membrane separation
CN101389309A (zh) * 2006-01-20 2009-03-18 莫诺索尔克斯有限公司 用于经粘膜给予活性组分的薄膜绷带
EP1996547A2 (de) * 2006-03-17 2008-12-03 Croda, Inc. Amin-/amid-funktionalisierte lipophile
CA2664097A1 (en) 2006-09-20 2008-03-27 Monosol Rx, Llc Edible water-soluble film containing a foam reducing flavoring agent
US20080268022A1 (en) * 2007-02-23 2008-10-30 Mccabe R Tyler Mehtods for treating and preventing ailments caused by human papillomavirus
US8475832B2 (en) 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
CN103209681B (zh) 2010-06-10 2017-05-24 Mida科技有限公司 纳米颗粒薄膜递送***
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
JO3456B1 (ar) 2015-05-13 2020-07-05 H Lundbeck As فيروتيوكسيتين بيروجلوتامات
CN109310646A (zh) 2016-05-05 2019-02-05 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US10723716B2 (en) 2016-12-21 2020-07-28 New York University Alpha-helix mimetics as modulators of Abeta self-assembly
US11124479B2 (en) 2017-07-14 2021-09-21 New York University Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization
US10500197B2 (en) 2017-07-18 2019-12-10 New York University Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2102172C3 (de) * 1971-01-18 1980-03-20 Dr. Karl Thomae Gmbh, 7950 Biberach Neue Mittel zur Behandlung und Pflege der Haut
LU74438A1 (de) * 1976-02-26 1977-09-12
JPS59184135A (ja) * 1983-04-04 1984-10-19 Teijin Ltd グリセリンピログルタミン酸エステル類を含有する医薬品組成物
JPS60214744A (ja) * 1984-04-06 1985-10-28 Nitto Electric Ind Co Ltd 薬物の経皮吸収促進助剤及びこれを含有する外用医薬組成物
JPS61103840A (ja) * 1984-10-26 1986-05-22 Nitto Electric Ind Co Ltd 外皮投与用組成物

Also Published As

Publication number Publication date
US4789667A (en) 1988-12-06
EP0173990A2 (de) 1986-03-12
JPS6160620A (ja) 1986-03-28
MY100947A (en) 1991-05-31
EP0173990A3 (en) 1987-05-13
EP0173990B1 (de) 1990-07-11

Similar Documents

Publication Publication Date Title
DE3578620D1 (de) Arzneimittel zur aeusserlichen anwendung.
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
DE3579655D1 (de) Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
ATE84215T1 (de) Arzneizubereitung zur oralen anwendung.
DE3580304D1 (de) Arzneimittel.
DE3750431D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung.
DE68902572D1 (de) Maskieren des geschmacks des thymols.
FI875326A (fi) Ljusbestraolningsanordning foer medicinal vaord av oera.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
DE3576276D1 (de) Phenothiazine enthaltende arzneimittel.
FI841448A (fi) Anordning foer upprullning av en materialbana, speciellt en pappersbana, pao en hylsa.
DE3586251D1 (de) Kosmetisches praeparat.
FI862590A0 (fi) Farmaceutiska produkter.
FI850455L (fi) Farmaceutiska produkter.
NO855067L (no) Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
FI852658A0 (fi) Farmaceutiska aemnen.
EP0084053A4 (de) Arzneimittel und die Verwendung von Sn- oder Cr-Protoporphyrin zu dessen Herstellung.
NO165637C (no) Fremgangsmaate for fremstilling av etoksylert lignitt.
DE3781045D1 (de) Antirheumatisches arzneimittel.
DE68907609D1 (de) Arzneimittelzusammensetzung.
DE3889327D1 (de) Platinkomplexe enthaltende arzneimittel.
PT81254A (de) Arzneimittel mit grf-wirkung
DE3580263D1 (de) 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles arzneimittel.
DE3887237D1 (de) Arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee